1. ACC2010 热点 中国医科大学附属盛京医院 庞文跃

2. 2010 年美国心脏病学会年会（ ACC ）于 3 月 14 日至 16 日在美国南部 城市亚特兰大国际会议中心举 行。 来自世界各地的 23000 名代表参加 了本届大会。会议共收到来自 世界各地的论文摘要 11000 篇， 经专家评审后有 4000 余篇被本 届大会录用。 本届大会聚焦的热点有心血管保健 、冠心病、瓣膜病、先天性心 脏病、心房纤颤、卫生信息技 术（ IT ）和影像学

3. Late-Breaking Clinical Trials Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Lipid Study Effects of Intensive Blood Pressure Control on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial Rethinking Lower BP Goals for Diabetics with Documented Coronary Artery Disease: Findings from the INternational VErapamil SR - Trandolapril STudy (INVEST) The Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Primary Safety and Efficacy Endpoints of the EVEREST II Randomized Clinical Trial

4. Late-Breaking Clinical Trials Randomized All-comer Comparison of Zotarolimus-eluting and Sirolimus-eluting Coronary Stents: 18-month Follow-up in the SORT OUT III Trial Randomized Trial of a Polymer-Free Dual Drug-Eluting Stent versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents - Two-year Clinical and Angiographic Outcomes First Report of the PERSEUS Randomized Controlled Trial Comparison of a Novel Platinum- Chromium, Thin-Strut TAXUS Element Stent Versus the TAXUS Express Stent in de novo Coronary Stenoses Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications after Drug-eluting Stent Implantation for Coronary Heart Disease : Influence of Cilostazol- based triple anti-platelet therapy on Ischemic Complication after drug-eluting stent implantation (CILON-T) study Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation: A Randomized, Multi-Center Trial

5. Late-Breaking Clinical Trials Effect of Genotyping Warfarin Patients on Outcomes: Results from The National Community-based Medco-Mayo Warfarin Effectiveness Study (MM-WES) The Diuretic Optimization Strategies Evaluation (DOSE) Study: A Randomized, Double Blind, Placebo-controlled Trial Of Diuretic Strategies In Acute Decompensated Heart Failure Effect of the Direct Renin Inhibitor Aliskiren on Left Ventricular Remodeling Following Myocardial Infarction with Left Ventricular Dysfunction: ASPIRE Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction: A Propensity Score-Matched Analysis Influence of Reduction of Left Ventricular Volume on Outcome After Coronary Artery Bypass Grafting With or Without Surgical Ventricular Reconstruction

6. Late-Breaking Clinical Trials Randomized Comparison of Angiojet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting to Direct Stenting Alone in Patients with Acute Myocardial Infarction: the Jetstent Trial Long-term Outcome after Drug-Eluting versus Bare-Metal Stent Implantation in Patients with ST-Elevation Myocardial Infarction. Three-year follow-up of the DEDICATION Trial Five Year Follow-up After Primary Percutaneous Coronary Intervention With A Paclitaxel-eluting Stent Versus A Bare-metal Stent In Acute ST-segment Elevation Myocardial Infarction. A Follow-up Study Of The PASSION-Trial Ticagrelor Versus Clopidogrel In Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: Results From The PLATO Trial A Randomized Trial Radial Artery Grafts versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery: VA Cooperative Study

7. Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Lipid Study ------- 评价联合血脂干预对 2 型糖尿病患者心血 管事件的影响

8. Effects of Intensive Blood Pressure Control on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial Effects of Intensive Blood Pressure Control on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial ------- 评价强化降压对 2 型糖尿病患者心血 管 事件的影响

9. Randomized All-comer Comparison of Zotarolimus-eluting and Sirolimus-eluting Coronary Stents: 18-month Follow-up in the SORT OUT III Trial ------- 对比两种药物支架植入后 18 个月时的疗 效

10. Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation: A Randomized, Multi-Center TrialOptimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation: A Randomized, Multi-Center Trial ------- 评价药物支架植入后，应用双重抗血小 板的时长

11. Primary Safety and Efficacy Endpoints of the EVEREST II Randomized Clinical Trial Primary Safety and Efficacy Endpoints of the EVEREST II Randomized Clinical Trial ---- 比较传统外科手术和介入治疗二尖瓣关闭 不全的疗效和安全性

12. 谢